October 2025
1. CACERES A, Shibata NM, Davalos-Gutierrez CD, Sarode GV, et al
   Inactivation of Atp7b copper transporter in intestinal epithelial cells is associated with altered lipid processing and cell growth machinery independent from hepatic copper accumulation and severity of liver histology.
   Am J Pathol. 2025 Oct 16:S0002-9440(25)00379.
   

   >> Share

   
   
2. LI N, Wu S, Li X, Yan M, et al
   Peroxisome Proliferator-Activated Receptor Agonist IVA337 Alleviates Inflammation and Fibrosis in MASH by Restoring Lipid Homeostasis.
   Am J Pathol. 2025;195:1822-1838.
   

   >> Share

   
   September 2025
3. JAIN S, Mukherjee R, Williams G, Liu JJ, et al
   Hepatocyte-specific MET deletion exacerbates acetaminophen-induced hepatotoxicity in mice.
   Am J Pathol. 2025 Sep 30:S0002-9440(25)00367.
   

   >> Share

   
   
4. WANG Z, Xu Q, Wang M, Xiao Q, et al
   Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients and Mice with Wilson Disease.
   Am J Pathol. 2025;195:1600-1618.
   

   >> Share

   
   August 2025
5. OMAR DY, Willoughby MM, Mostafa N, Otakhor K, et al
   Lipid Droplet Dynamics in Alcoholic Steatohepatitis.
   Am J Pathol. 2025 Aug 26:S0002-9440(25)00299.
   

   >> Share

   
   July 2025
6. LIU W, Lin YT, Han DG, Shi AC, et al
   Enhancement of TNFalpha-mediated hepatic apoptosis and liver injury by Hepatitis B virus surface antigen.
   Am J Pathol. 2025 Jul 24:S0002-9440(25)00247.
   

   >> Share

   
   
7. LIU J, Li J, Li Y, Wei M, et al
   Transcription Factor YY2 Inhibits Tumor Cell Glutamine Catabolism by Regulating GLS1 RNA Splicing Isoform GAC.
   Am J Pathol. 2025;195:1340-1357.
   

   >> Share

   
   June 2025
8. ZHONG H, Liu C, Huang Z, Tan P, et al
   Crosstalk between Hepatic Stellate Cells and Hepatic Macrophages in Metabolic Dysfunction-Associated Steatohepatitis.
   Am J Pathol. 2025;195:1040-1056.
   

   >> Share

   
   May 2025
9. XUE Y, Tian T, Ottallah M, Mannan M, et al
   Alcohol-Associated Hepatocarcinogenesis: Wnt/beta-Catenin in Action.
   Am J Pathol. 2025 May 9:S0002-9440(25)00156-7. doi: 10.1016/j.ajpath.2025.
   

   >> Share

   
   
10. KEEGAN A, Malamal G, Lee Y, Korolowicz K, et al
    Multimodal Diagnostic Imaging of Metabolic Dysfunction-Associated Steatotic Liver Disease: Noninvasive Analyses by Photoacoustic Ultrasound and Magnetic Resonance Imaging.
    Am J Pathol. 2025;195:875-890.
    

    >> Share

    
    April 2025
11. RODEMANN MM, Dreschmann V, Dorner E, Sommer A, et al
    Identification of a growth-promoting gene cluster in the region 2q24 as a driver of tumorigenesis in childhood hepatoblastoma.
    Am J Pathol. 2025 Apr 30:S0002-9440(25)00147.
    

    >> Share

    
    
12. XU L, Zhao Y, Yang Y, Qi E, et al
    Constitutive hepatic mTORC1 activation aggravates alcohol-induced liver injury via endoplasmic reticulum stress-mediated ferroptosis.
    Am J Pathol. 2025 Apr 7:S0002-9440(25)00106-3. doi: 10.1016/j.ajpath.2025.
    

    >> Share

    
    March 2025
13. WANG Z, Liang G, Peng J, Gu Y, et al
    Sirtuin 7 Promotes Alcohol-Associated Liver Injury via Modulating Myeloid Cell Chemokine (C-C Motif) Ligand 2 Secretion through the NF-kappaB Signaling Pathway.
    Am J Pathol. 2025;195:575-588.
    

    >> Share

    
    
14. CASILLAS-RAMIREZ A, Maroto-Serrat C, Sanus F, Mico-Carnero M, et al
    Regulation of Adiponectin and Resistin in Liver Transplantation Protects Grafts from Extended-Criteria Donors.
    Am J Pathol. 2025;195:494-527.
    

    >> Share

    
    February 2025
15. KHA M, Magnusson Y, Johansson I, Altiparmak G, et al
    Injured Proximal Tubular Epithelial Cells Lose Hepatocyte Nuclear Factor 4alpha Expression Crucial for Brush Border Formation and Transport.
    Am J Pathol. 2025 Feb 13:S0002-9440(25)00047.
    

    >> Share

    
    January 2025
16. CHEN K, Wang H, Ma B, Knapp J, et al
    Gas1-Mediated Suppression of Hepatoblastoma Tumorigenesis.
    Am J Pathol. 2025 Jan 29:S0002-9440(25)00037.
    

    >> Share

    
    
17. ISHIHARA N, Koma YI, Omori M, Komatsu S, et al
    CCL2/CCR2/Erk Signal Induced through Cancer Cell-Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression.
    Am J Pathol. 2025 Jan 3:S0002-9440(24)00480-2. doi: 10.1016/j.ajpath.2024.
    

    >> Share

    
    December 2024
18. HUANG X, Zheng S, Li S, Huang Y, et al
    Machine learning-based pathomics model predicts ANGPT2 expression and prognosis in hepatocellular carcinoma.
    Am J Pathol. 2024 Dec 31:S0002-9440(24)00478.
    

    >> Share

    
    
19. ZUO R, Wang M, Wang YT, ShenTu Y, et al
    Ablation of Hepatic Asah1 Gene Disrupts Hepatic Lipid Homeostasis and Promotes Fibrotic Nonalcoholic Steatohepatitis in Mice.
    Am J Pathol. 2024 Dec 20:S0002-9440(24)00444.
    

    >> Share

    
    November 2024
20. TUFFS C, Dupovac M, Richter K, Holten S, et al
    Genetic Loss of HIF-Prolyl-Hydroxylase (PHD) 1, but not pharmacological Inhibition, mitigates hepatic fibrosis.
    Am J Pathol. 2024 Nov 18:S0002-9440(24)00411.
    

    >> Share

    
    
21. ZHANG H, Lei S, Zhuo H, Xu Y, et al
    TRIM24 Up-Regulates ORM2 to Alleviate Abnormal Lipid Metabolism, Inflammation, and Oxidative Stress in Mice with Obstructive Sleep Apnea Syndrome and Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Am J Pathol. 2024;194:2091-2105.
    

    >> Share

    
    
22. LI Z, Sun T, He Z, Li Z, et al
    Intestinal Dysbacteriosis Contributes to Persistent Cognitive Impairment after Resolution of Acute Liver Failure.
    Am J Pathol. 2024;194:2076-2090.
    

    >> Share

    
    October 2024
23. HUANG CC, Wang CH, Yeh HY, Tsai HC, et al
    Chronic Peroxisome Proliferator-Activated Receptor alpha/gamma and Cannabinoid Receptor 2 Agonist Treatments Attenuated Visceral Adipose Tissue (VAT)-Derived Extracellular Vesicle-Related VAT and Intestinal Abnormalities in Nonalcoholic Steatohepatitis
    Am J Pathol. 2024 Oct 26:S0002-9440(24)00398.
    

    >> Share

    
    September 2024
24. GUEST RV, Goeppert B, Nault JC, Sia D, et al
    Morphomolecular pathology and Genomic Insights into the Cells of Origin of Cholangiocarcinoma and combined Hepatocellular-Cholangiocarcinoma.
    Am J Pathol. 2024 Sep 26:S0002-9440(24)00357.
    

    >> Share

    
    
25. CHEON I, Kim M, Kim KH, Ko S, et al
    Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology.
    Am J Pathol. 2024 Sep 24:S0002-9440(24)00358.
    

    >> Share

    
    
26. LI J, Ding X, Yan W, Liu K, et al
    Tumor-derived Immunoglobulin-like transcript 4 promotes postoperative relapse via inducing vasculogenic mimicry through MAPK/ERK signaling in hepatocellular carcinoma.
    Am J Pathol. 2024 Sep 2:S0002-9440(24)00329-8. doi: 10.1016/j.ajpath.2024.
    

    >> Share

    
    August 2024
27. JIANG L, Xu QY, Zhou YC, Xu J, et al
    Spatial transcriptomics reveals the transcriptomic signatures in a mouse model of pediatric metabolic dysfunction-associated steatohepatitis.
    Am J Pathol. 2024 Aug 31:S0002-9440(24)00327.
    

    >> Share

    
    
28. LEYA M, Jeong H, Yang D, Bao THTN, et al
    Hepatocyte-specific casein kinase 1 epsilon ablation ameliorates metabolic dysfunction-associated steatohepatitis by upregulating TRAF3 in mice.
    Am J Pathol. 2024 Aug 21:S0002-9440(24)00299.
    

    >> Share

    
    
29. AFF? S, Sererols-Vinas L, Garcia-Vicien G, Cadamuro M, et al
    Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis.
    Am J Pathol. 2024 Aug 6:S0002-9440(24)00279-7. doi: 10.1016/j.ajpath.2024.
    

    >> Share

    
    
30. PANT K, Gradilone SA
    NAMPT Overexpression Drives Cell Growth in Polycystic Liver Disease through Mitochondrial Metabolism Regulation.
    Am J Pathol. 2024;194:1528-1537.
    

    >> Share

    
    July 2024
31. YANG L, Pham K, Xi Y, Jiang S, et al
    Acyl-CoA Synthetase Medium Chain Family Member 5 Mediated Fatty Acid Metabolism Dysregulation Promotes the Progression of Hepatocellular Carcinoma.
    Am J Pathol. 2024 Jul 26:S0002-9440(24)00244.
    

    >> Share

    
    June 2024
32. LAURENT-BELLUE A, Sadraoui A, Claude L, Calderaro J, et al
    Deep learning classification and quantification of pejorative and non-pejorative architectures in resected hepatocellular carcinoma from digital histopathological images.
    Am J Pathol. 2024 Jun 13:S0002-9440(24)00206.
    

    >> Share

    
    
33. ZHANG Y, Liu Y, Huo W, He L, et al
    The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases.
    Am J Pathol. 2024;194:879-893.
    

    >> Share

    
    May 2024
34. MARTUCCI NJ, Stoops J, Bowen W, Orr A, et al
    A novel role for the phosphatidylinositol-4,5-bisphosphate 3-kinase delta isoform in hepatocellular proliferation.
    Am J Pathol. 2024 May 3:S0002-9440(24)00168-8. doi: 10.1016/j.ajpath.2024.
    

    >> Share

    
    April 2024
35. HU J, Xu H, Ma X, Bai M, et al
    Modulating PCGF4 Stability Is an Efficient Metastasis-Regulatory Strategy Used by Distinct Subtypes of Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma.
    Am J Pathol. 2024 Apr 24:S0002-9440(24)00160.
    

    >> Share

    
    March 2024
36. NGO HV, Thanh Le TT, Vu HN, Hoang H, et al
    Poorly Differentiated Hepatocellular Carcinoma Cells Avoid Apoptosis by Interacting with T Cells via CD40-CD40L Linkage.
    Am J Pathol. 2024 Mar 26:S0002-9440(24)00117.
    

    >> Share

    
    
37. YU YP, Liu S, Geller D, Luo JH, et al
    Serum fusion transcripts to assess the risk of hepatocellular carcinoma and the impact of cancer treatment through machine learning.
    Am J Pathol. 2024 Mar 25:S0002-9440(24)00111.
    

    >> Share

    
    February 2024
38. NEWBERRY EP, Molitor EA, Liu A, Chong K, et al
    Impaired hepatic VLDL secretion promotes tumorigenesis and is accelerated with Fabp1 deletion.
    Am J Pathol. 2024 Feb 26:S0002-9440(24)00074.
    

    >> Share

    
    
39. LIAN V, Hinrichs H, Young M, Faerber A, et al
    Maternal Obesogenic Diet Attenuates Microbiome-Dependent Offspring Weaning Reaction with Worsening of Steatotic Liver Disease.
    Am J Pathol. 2024;194:209-224.
    

    >> Share

    
    
40. ABUDUYIMITI T, Goto H, Kimura K, Oshima Y, et al
    Diabetes accelerates steatohepatitis in mice: liver pathology and single-cell gene expression signatures.
    Am J Pathol. 2024 Feb 1:S0002-9440(24)00037-3. doi: 10.1016/j.ajpath.2024.
    

    >> Share

    
    December 2023
41. TAN PK, Ostertag T, Rosenthal SB, Chilin-Fuentes D, et al
    Role of Hepatic Stellate and Liver Sinusoidal Endothelial Cells in a Human Primary Cell Three-Dimensional Model of Nonalcoholic Steatohepatitis.
    Am J Pathol. 2023 Dec 28:S0002-9440(23)00484.
    

    >> Share

    
    
42. WEN T, Xie J, Ma L, Hao Z, et al
    Vitamin D receptor activation reduces hepatic inflammation via enhancing macrophage autophagy in cholestatic mice.
    Am J Pathol. 2023 Dec 15:S0002-9440(23)00462.
    

    >> Share

    
    
43. JIANG C, Saiki Y, Hirota S, Iwata K, et al
    Ablation of Dual-Specificity Phosphatase 6 Protects against Nonalcoholic Fatty Liver Disease via Cytochrome P450 4A and Mitogen-Activated Protein Kinase.
    Am J Pathol. 2023;193:1988-2000.
    

    >> Share

    
    
44. VENKATESAN N, Doskey LC, Malhi H
    The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis.
    Am J Pathol. 2023;193:1887-1899.
    

    >> Share

    
    November 2023
45. WARNER JB, Hardesty JE, Song YL, Floyd AT, et al
    Hepatic Transcriptome and Its Regulation Following Soluble Epoxide Hydrolase Inhibition in Alcohol-Associated Liver Disease.
    Am J Pathol. 2023 Nov 2:S0002-9440(23)00410-8. doi: 10.1016/j.ajpath.2023.
    

    >> Share

    
    October 2023
46. FENG R, Tong C, Lin T, Liu H, et al
    Insulin determines TGF-beta effects on HNF4alpha transcription in hepatocytes.
    Am J Pathol. 2023 Oct 9:S0002-9440(23)00365-6. doi: 10.1016/j.ajpath.2023.
    

    >> Share

    
    
47. MAIERS JL, Chakraborty S
    The Cellular, Molecular, and Pathologic Consequences of Stress on the Liver.
    Am J Pathol. 2023;193:1353-1354.
    

    >> Share

    
    
48. ISMAIL A, Kennedy L, Francis H
    Sex-Dependent Differences in Cholestasis: Why Estrogen Signaling May Be a Key Pathophysiological Driver.
    Am J Pathol. 2023;193:1355-1362.
    

    >> Share

    
    
49. BANERJEE P, Gaddam N, Chandler V, Chakraborty S, et al
    Oxidative Stress-Induced Liver Damage and Remodeling of the Liver Vasculature.
    Am J Pathol. 2023;193:1400-1414.
    

    >> Share

    
    
50. JACKSON KG, Way GW, Zeng J, Lipp MK, et al
    The Dynamic Role of Endoplasmic Reticulum Stress in Chronic Liver Disease.
    Am J Pathol. 2023;193:1389-1399.
    

    >> Share

    
    
51. ALI N, Ferrao K, Mehta KJ
    Liver Iron Loading in Alcohol-Associated Liver Disease.
    Am J Pathol. 2023;193:1427-1439.
    

    >> Share

    
    September 2023
52. FITZGERALD H, Bonin JL, Khan S, Eid M, et al
    Resolvin D2-GPR18 Enhances Bone Marrow Function and Limits Steatosis and Hepatic Collagen Accumulation in Aging.
    Am J Pathol. 2023 Sep 15:S0002-9440(23)00322.
    

    >> Share

    
    
53. TANAKA M, Jeong J, Thomas C, Zhang X, et al
    The sympathetic nervous system promotes hepatic lymphangiogenesis, which is protective against liver fibrosis.
    Am J Pathol. 2023 Sep 4:S0002-9440(23)00308-5. doi: 10.1016/j.ajpath.2023.
    

    >> Share

    
    
54. CHAN KK, Au KY, Suen LH, Leung B, et al
    SORTILIN-DRIVEN CANCER SECRETOME ENHANCES TUMORIGENIC PROPERTIES OF HEPATOCELLULAR CARCINOMA VIA DE NOVO LIPOGENESIS.
    Am J Pathol. 2023 Sep 4:S0002-9440(23)00310-3. doi: 10.1016/j.ajpath.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share